ʻO ka lāʻau lapaʻau mpox MVA-BN Vaccine (ʻo ia hoʻi, Modified Vaccinia Ankara vaccine i hana ʻia e Bavarian Nordic A/S) ua lilo i ka lāʻau lapaʻau Mpox mua i hoʻohui ʻia i ka papa inoa prequalification o WHO. ʻO "Imvanex" ka inoa kālepa o kēia kano.
ʻO ka mana prequalification e WHO e hoʻomaikaʻi i ka loaʻa ʻana o ka lāʻau lapaʻau mpox ma o ka loaʻa wikiwiki ʻana e nā aupuni a me nā hui honua no nā kaiāulu ma ʻApelika e pono ai e hoʻopaʻa i ka maʻi mpox.
Loaʻa i ka lāʻau lapaʻau ʻo Imvanex a i ʻole MVA-NA ka maʻi maʻi maʻi maʻi maʻi maʻi ʻo Ankara i hoʻemi ʻia a nāwaliwali paha i hiki ʻole ke hana hou i loko o ke kino.
I ka makahiki 2013, ua ʻae ʻia ʻo Imvanex ma ke ʻano he kano liʻiliʻi e ka European Medicines Agency.
Mai ka 22 Iulai 2022, ua ʻae ʻia ia ma lalo o nā kūlana kūikawā e ka European Medicines Agency no ka hoʻohana ʻana ma European Union ma ke ʻano he kano Mpox pū kekahi. Ma UK, ua ʻae ʻia ka MVA (Imvanex) ma ke ʻano he kano kūʻē i ka mpox a me ka maʻi maʻi liʻiliʻi e ka Medicines and Healthcare products Regulatory Agency (MHRA).
Manaʻo ʻia ka lāʻau lapaʻau MVA-BN i nā pākeke ma luna o 18-makahiki ma ke ʻano he 2-dose injection i lawelawe ʻia he 4 pule kaʻawale.
Manaʻo ʻo WHO i ka hoʻohana ʻana i ka hoʻohana ʻana i ka hoʻohana ʻana i ka hoʻohana ʻana i nā kūlana outbreak.
Hōʻike ka ʻikepili i loaʻa i ka lāʻau lapaʻau MVA-BN pākahi hoʻokahi i hāʻawi ʻia ma mua o ka hoʻolaha ʻana he 76% ka maikaʻi i ka pale ʻana i ka poʻe mai mpox, me ka papa hana 2-dose e loaʻa ana i ka 82% kūpono.
ʻAʻole ʻoi aku ka maikaʻi o ka lāʻau lapaʻau ma hope o ka hoʻolaha ʻana ma mua o ka hoʻolaha ʻana.
ʻO ka piʻi ʻana o ka mpox outbreak ma DR Congo a me nā ʻāina ʻē aʻe i haʻi ʻia he pilikia olakino olakino o ka hopohopo honua (PHEIC) ma 14 ʻAukake 2024.
Ma luna o 120 mau ʻāina ua hōʻoia ʻoi aku ma mua o 103 000 mau hihia o ka mpox mai ka hoʻomaka ʻana o ka maʻi maʻi honua ma 2022. Ma 2024 wale nō, aia he 25 237 mau hihia i hoʻopaʻa ʻia a hoʻopaʻa ʻia a me 723 mau make mai nā maʻi like ʻole ma 14 mau ʻāina o ka ʻĀpana ʻApelika (ma muli o ʻikepili mai 8 Kepakemapa 2024).
***
Sources:
- Nūhou WHO - Hoʻoholo mua ʻo WHO i ke kano mua e kūʻē i ka mpox. Published 13 September 2024. Loaʻa ma https://www.who.int/news/item/13-09-2024-who-prequalifies-the-first-vaccine-against-mpox
- EMA. ʻO Imvanex - ka maʻi maʻi maʻi liʻiliʻi a me ka monkeypox (Live Modified Vaccinia Virus Ankara). Hana hou ʻia: 10 Kepakemapa 2024. Loaʻa ma https://www.ema.europa.eu/en/medicines/human/EPAR/imvanex
- Hoʻokuʻu paʻi - Loaʻa iā Bavarian Nordic ka manaʻo CHMP maikaʻi no ka hoʻokomo ʻana i ka ʻikepili pono honua maoli i ka mana kūʻai kūʻai ʻEulopa no ka maʻi maʻi liʻiliʻi a me ka mpox. Hoʻopuka ʻia 26 Iulai 2024. Loaʻa ma https://www.bavarian-nordic.com/media/media/news.aspx?news=6965
***
Nā pāhana pili:
- ʻO ka maʻi ʻo Monkeypox (Mpox): Hoʻomaka ʻo WHO i ke kaʻina hana EUL (10 Aukake 2024)
- Hoʻolaha ʻia ʻo Virulent Strain of Monkeypox (MPXV) ma o ka pili ʻana i ka moekolohe(20 ʻApelila 2024)
- E hele anei ʻo Monkeypox ma ke ala Corona? (23 Iune 2022)
***
 has become the first Mpox vaccine to be added to the prequalification list of WHO. “Imvanex” is the trade name of this vaccine.){kind=link}